-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RBDxz8bH7PfAe6RMBo3u0hGp2aRe4L3PCpg8iVoIrGDvEOMEVMhO70xvd4EIAL9p ZaU4GQLGKUiZzfyJAagNuA== 0001476010-09-000001.txt : 20091105 0001476010-09-000001.hdr.sgml : 20091105 20091105103918 ACCESSION NUMBER: 0001476010-09-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091105 DATE AS OF CHANGE: 20091105 EFFECTIVENESS DATE: 20091105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Afferent Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001476010 IRS NUMBER: 271116683 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-135875 FILM NUMBER: 091159989 BUSINESS ADDRESS: STREET 1: C/O THIRD ROCK VENTURES, L.P. STREET 2: 29 NEWBURY STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-585-2000 MAIL ADDRESS: STREET 1: C/O THIRD ROCK VENTURES, L.P. STREET 2: 29 NEWBURY STREET CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0603 D LIVE 0001476010 Afferent Pharmaceuticals, Inc. THIRD ROCK VENTURES, L.P. 29 NEWBURY STREET BOSTON MA 02116 617-585-2000 DELAWARE None None Corporation true 2009 Kevin Starr Third Rock Ventures, L.P. 29 Newbury Street Boston MA 02116 Executive Officer Director President David Neafus Third Rock Ventures, L.P. 29 Newbury Street Boston MA 02116 Executive Officer Chief Financial Officer & Treasurer Mitchell S. Bloom Goodwin Procter LLP Exchange Place Boston MA 02109 Executive Officer Secretary Jesse Treu Domain Associates, LLC One Palmer Square, Suite 515 Princeton NJ 08542 Director Liam Ratcliffe New Leaf Venture Partners 7 Times Square, Suite 1603 New York NY 10036 Director Arthur Pappas Pappas Ventures 2520 Meridian Parkway, Suite 400 Durham NC 27713 Director Other Health Care Decline to Disclose 06 false 2009-10-23 false true Convertible Promissory Notes false 0 150000 150000 0 false 6 0 0 0 true false Afferent Pharmaceuticals, Inc. David Neafus David Neafus Chief Financial Officer & Treasurer 2009-10-30 -----END PRIVACY-ENHANCED MESSAGE-----